Skip to main content
. 2022 Jun 14;15:5615–5626. doi: 10.2147/IJGM.S368881

Table 1.

Comparison of Clinical Variables Between Male and Female in 574 PMV Patients

Male Female P OR
(N=357) (N=217)
Successfully weaned, No (%) 242(67.8%) 149(68.7%) 0.854 0.960
Ventilator-dependent, No (%) 55(15.4%) 28(12.9%) 0.463 1.229
RCC mortality, No (%) 59(16.5%) 36(16.6%) 1.000 0.995
Ward mortality, No (%) 51(14.3%) 35(16.1%) 0.549 0.867
In-hospital mortality, No (%) 113(31.7%) 73(33.6%) 0.646 0.914
Age Groups, No (%)
Age <45 Y/O 11(3.1%) 6(2.8%) 1.000 1.118
Age 45–54 Y/O 36(10.1%) 17(7.8%) 0.457 1.319
Age 55–64 Y/O 54(15.1%) 22(10.1%) 0.099 1.580
Age 65–74 Y/O 79(22.1%) 39(18.0%) 0.243 1.297
Age 75–84 Y/O 122(34.2%) 89(41.0%) 0.108 0.747
Age ≥85 Y/O 55(15.4%) 44(20.3%) 0.140 0.716
Causes of respiratory failure
Pneumonia 142(39.8%) 67(30.9%) 0.032 1.479
Intracranial hemorrhage 68(19.1%) 41(18.9%) 1.000 1.010
Sepsis 22(6.2%) 31(14.3%) 0.002 0.394
COPD 23(6.4%) 8(3.7%) 0.185 1.799
Cardiac disease 13(3.6%) 18(8.3%) 0.022 0.418
Malignant disease 12(3.4%) 9(4.1%) 0.651 0.804
Post operation 24(6.7%) 15(6.9%) 0.930 0.971
Cervical-spine disease 10(2.8%) 1(0.5%) 0.059 6.225
Post-CPCR 6(1.7%) 5(2.3%) 0.755 0.725
Cerebral infarction 8(2.2%) 2(0.9%) 0.333 2.464
Miscellaneous causes 29(8.1%) 20(9.2%) 0.647 0.871
Comorbidity
Cardiovascular disease, No (%) 214(59.9%) 156(71.9%) 0.004 0.585
Chronic lung disease, No (%) 70(19.6%) 30(13.8%) 0.089 1.520
Chronic kidney disease, No (%) 35(9.8%) 27(12.4%) 0.334 0.765
End-stage renal disease, No (%) 28(7.8%) 16(7.4%) 0.873 1.069
Neurologic disease, No (%) 120(33.6%) 69(31.8%) 0.714 1.086
Metabolic disease, No (%) 118(33.1%) 88(40.1%) 0.073 0.724
Malignant disease, No (%) 58(16.2%) 23(10.6%) 0.064 1.636
Liver disease, No (%) 35(9.8%) 15(6.9%) 0.236 1.464

Abbreviations: PMV, prolonged mechanical ventilation; No, number; RCC, respiratory care center; COPD, chronic obstructive pulmonary disease; CRCP, Cardio-Pulmonary-Cerebral-Resuscitation; Y/O, years old.